Literature DB >> 25306204

The 4th Schizophrenia International Research Society Conference, 5-9 April 2014, Florence, Italy: a summary of topics and trends.

Olukayode Abayomi1, Davide Amato2, Candace Bailey3, Byron Bitanihirwe4, Lynneice Bowen5, Shimon Burshtein6, Alexis Cullen7, Montserrat Fusté8, Ana P Herrmann9, Babak Khodaie10, Sanja Kilian11, Qortni A Lang12, Elizabeth E Manning13, Raffael Massuda14, Milawaty Nurjono15, Sarosh Sadiq16, Teresa Sanchez-Gutierrez17, Tamara Sheinbaum18, Venkataram Shivakumar19, Nicholas Simon20, Anneliese Spiteri-Staines21, Suttajit Sirijit22, Nanna Gilliam Toftdahl23, Sunali Wadehra24, Yi Wang25, Rebekah Wigton26, Susan Wright27, Sergey Yagoda28, Yuliya Zaytseva29, Anne O'Shea30, Lynn E DeLisi31.   

Abstract

The 4th Schizophrenia International Research Society Conference was held in Florence, Italy, April 5-9, 2014 and this year had as its emphasis, "Fostering Collaboration in Schizophrenia Research". Student travel awardees served as rapporteurs for each oral session, summarized the important contributions of each session and then each report was integrated into a final summary of data discussed at the entire conference by topic. It is hoped that by combining data from different presentations, patterns of interest will emerge and thus lead to new progress for the future. In addition, the following report provides an overview of the conference for those who were present, but could not participate in all sessions, and those who did not have the opportunity to attend, but who would be interested in an update on current investigations ongoing in the field of schizophrenia research. Published by Elsevier B.V.

Entities:  

Keywords:  Brain imaging; Conference; Genetics; Gene–environment interaction; Meeting report; Schizophrenia; Treatment

Mesh:

Year:  2014        PMID: 25306204      PMCID: PMC4394607          DOI: 10.1016/j.schres.2014.08.032

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  155 in total

1.  Psychopathological mechanisms linking childhood traumatic experiences to risk of psychotic symptoms: analysis of a large, representative population-based sample.

Authors:  Martine van Nierop; Tineke Lataster; Feikje Smeets; Nicole Gunther; Catherine van Zelst; Ron de Graaf; Margreet ten Have; Saskia van Dorsselaer; Maarten Bak; Inez Myin-Germeys; Wolfgang Viechtbauer; Jim van Os; Ruud van Winkel
Journal:  Schizophr Bull       Date:  2014-03       Impact factor: 9.306

2.  Antipsychotics associated with the development of type 2 diabetes in antipsychotic-naïve schizophrenia patients.

Authors:  Jimmi Nielsen; Søren Skadhede; Christoph U Correll
Journal:  Neuropsychopharmacology       Date:  2010-06-02       Impact factor: 7.853

3.  Neuroanatomical maps of psychosis onset: voxel-wise meta-analysis of antipsychotic-naive VBM studies.

Authors:  Paolo Fusar-Poli; Joaquim Radua; Philip McGuire; Stefan Borgwardt
Journal:  Schizophr Bull       Date:  2011-11-10       Impact factor: 9.306

4.  Brain and ventricle instability during psychotic episodes of the schizophrenias.

Authors:  D L Garver; T R Nair; J D Christensen; J A Holcomb; S J Kingsbury
Journal:  Schizophr Res       Date:  2000-07-07       Impact factor: 4.939

5.  Randomized controlled trial of interventions for young people at ultra-high risk of psychosis: twelve-month outcome.

Authors:  Patrick D McGorry; Barnaby Nelson; Lisa J Phillips; Hok Pan Yuen; Shona M Francey; Annette Thampi; Gregor E Berger; G Paul Amminger; Magenta B Simmons; Daniel Kelly; Grad Dip; Andrew D Thompson; Alison R Yung
Journal:  J Clin Psychiatry       Date:  2012-11-27       Impact factor: 4.384

6.  The 3rd Schizophrenia International Research Society Conference, 14-18 April 2012, Florence, Italy: summaries of oral sessions.

Authors:  Brandon Abbs; Rashmin M Achalia; Adegoke O Adelufosi; Ahmet Yiğit Aktener; Natalie J Beveridge; Savita G Bhakta; Rachael K Blackman; Emre Bora; M S Byun; Maurice Cabanis; Ricardo Carrion; Christina A Castellani; Tze Jen Chow; M Dmitrzak-Weglarz; Charlotte Gayer-Anderson; Felipe V Gomes; Kristen Haut; Hiroaki Hori; Joshua T Kantrowitz; Taishiro Kishimoto; Frankie H F Lee; Ashleigh Lin; Lena Palaniyappan; Meina Quan; Maria D Rubio; Sonia Ruiz de Azúa; Saddichha Sahoo; Gregory P Strauss; Aleksandra Szczepankiewicz; Andrew D Thompson; Antonella Trotta; Laura M Tully; Hiroyuki Uchida; Eva Velthorst; Jared W Young; Anne O'Shea; Lynn E Delisi
Journal:  Schizophr Res       Date:  2012-08-19       Impact factor: 4.939

7.  Transient and selective overexpression of dopamine D2 receptors in the striatum causes persistent abnormalities in prefrontal cortex functioning.

Authors:  Christoph Kellendonk; Eleanor H Simpson; H Jonathan Polan; Gaël Malleret; Svetlana Vronskaya; Vanessa Winiger; Holly Moore; Eric R Kandel
Journal:  Neuron       Date:  2006-02-16       Impact factor: 17.173

8.  A randomized exploratory trial of an α-7 nicotinic receptor agonist (TC-5619) for cognitive enhancement in schizophrenia.

Authors:  Jeffrey A Lieberman; Geoffrey Dunbar; Anthony C Segreti; Ragy R Girgis; Frances Seoane; Jessica S Beaver; Naihua Duan; David A Hosford
Journal:  Neuropsychopharmacology       Date:  2012-12-18       Impact factor: 7.853

9.  Microduplications of 16p11.2 are associated with schizophrenia.

Authors:  Shane E McCarthy; Vladimir Makarov; George Kirov; Anjene M Addington; Jon McClellan; Seungtai Yoon; Diana O Perkins; Diane E Dickel; Mary Kusenda; Olga Krastoshevsky; Verena Krause; Ravinesh A Kumar; Detelina Grozeva; Dheeraj Malhotra; Tom Walsh; Elaine H Zackai; Paige Kaplan; Jaya Ganesh; Ian D Krantz; Nancy B Spinner; Patricia Roccanova; Abhishek Bhandari; Kevin Pavon; B Lakshmi; Anthony Leotta; Jude Kendall; Yoon-Ha Lee; Vladimir Vacic; Sydney Gary; Lilia M Iakoucheva; Timothy J Crow; Susan L Christian; Jeffrey A Lieberman; T Scott Stroup; Terho Lehtimäki; Kaija Puura; Chad Haldeman-Englert; Justin Pearl; Meredith Goodell; Virginia L Willour; Pamela Derosse; Jo Steele; Layla Kassem; Jessica Wolff; Nisha Chitkara; Francis J McMahon; Anil K Malhotra; James B Potash; Thomas G Schulze; Markus M Nöthen; Sven Cichon; Marcella Rietschel; Ellen Leibenluft; Vlad Kustanovich; Clara M Lajonchere; James S Sutcliffe; David Skuse; Michael Gill; Louise Gallagher; Nancy R Mendell; Nick Craddock; Michael J Owen; Michael C O'Donovan; Tamim H Shaikh; Ezra Susser; Lynn E Delisi; Patrick F Sullivan; Curtis K Deutsch; Judith Rapoport; Deborah L Levy; Mary-Claire King; Jonathan Sebat
Journal:  Nat Genet       Date:  2009-10-25       Impact factor: 38.330

10.  Impaired rich club connectivity in unaffected siblings of schizophrenia patients.

Authors:  Guusje Collin; René S Kahn; Marcel A de Reus; Wiepke Cahn; Martijn P van den Heuvel
Journal:  Schizophr Bull       Date:  2013-12-02       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.